反应 #471141
ord-e3eab900c1db45568cb555b2baf487b5
反应方程式
反应物
试剂
反应条件
后处理
- 1其他before being partitioned between 2M aqueous hydrochloric acid and ethyl acetate
- 2洗涤The organic layer was washed with saturated aqueous sodium bicarbonate solution and brine
- 3干燥before being dried over magnesium sulphate
- 4其他evaporated in vacuo
- 5workup.DISSOLUTIONThe residue was dissolved in 4M hydrogen chloride in dioxane
- 6workup.STIRRINGstirred for 7 hours at room temperature
- 7其他The reagent was removed in vacuo
- 8其他the residue partitioned between ethyl acetate and saturated aqueous sodium bicarbonate solution
- 9洗涤The separated organic fraction was washed with brine
- 10干燥before being dried over magnesium sulphate
- 11其他evaporated in vacuo
- 12其他The crude material was purified by column chromatography (silica)
- 13洗涤eluting with methanol
实验过程
A solution of (2R)-{[(2R)-2-[(tert-butoxycarbonyl)amino]-2-(2,3-dihydro-1H-inden-2-yl)ethanoyl][(1R)-1-(methoxycarbonyl)-3-methylbutyl]amino}(4-fluorophenyl)ethanoic acid (73 mg) in N,N-dimethylformamide (2 ml) was sequentially treated with diisopropylethylamine (51 μL), phosphorus, (1-hydroxy-1H-benzotriazolato-O)tri-1-pyrrolidinyl-(T-4)-hexafluorophosphate (80 mg) and then after 2 minutes, 2,2,2-trifluoroethylamine (25 μl). This reaction mixture was stirred for 2 hours before being partitioned between 2M aqueous hydrochloric acid and ethyl acetate. The organic layer was washed with saturated aqueous sodium bicarbonate solution and brine before being dried over magnesium sulphate and evaporated in vacuo. The residue was dissolved in 4M hydrogen chloride in dioxane and stirred for 7 hours at room temperature. The reagent was removed in vacuo and the residue partitioned between ethyl acetate and saturated aqueous sodium bicarbonate solution. The separated organic fraction was washed with brine before being dried over magnesium sulphate and evaporated in vacuo. The crude material was purified by column chromatography (silica) eluting with methanol: dichloromethane (1% to 3%) to furnish ((2R)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-2-(4-fluorophenyl)-N-(2,2,2-trifluoroethyl)ethanamide (10 mg)